SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
NATURA &CO HOLDING S.A.
|
|
|
|
|
|
By:
|
/s/ José Antonio
de Almeida Filippo
|
|
Name:
|
José Antonio de Almeida Filippo
|
|
Title:
|
Principal Financial Officer
|
|
|
|
|
|
By:
|
/s/ Itamar Gaino
Filho
|
|
Name:
|
Itamar Gaino Filho
|
|
Title:
|
Chief Legal and Compliance Officer
|
Date: March 5, 2021
Item 1
Earnings
release of Natura &Co Holding S.A. for the fourth quarter of 2020.
São
Paulo, March 4, 2021
Q4-20:
Natura &Co reports strong sales growth of 24%1 and net profit up 200%
The Group strongly outperformed
the global CFT market by over 6 pp2 in both the quarter and year,
with strong contribution
from digital social selling and e-commerce.
Phased investments in branding,
R&D and technology in Q4 to support continued sustainable growth.
|
·
|
Natura
&Co’s consolidated net revenue reached R$12.0 billion in Q4, up 24.3% in BRL vs. the same quarter last year
(+6.4% at constant currency, “CC”), with sustained growth in digital sales across all brands, significantly outperforming
the global CFT market in the quarter and full year by approximately 6 pp2 in CC. In FY20, net revenue reached
R$36.9 billion, up 12.1% in BRL vs. FY19 (-2.3% at CC).
|
|
·
|
Natura
&Co Latam’s1 Q4 net
revenue increased by 20.5% in BRL (+13.0% at CC). The combined market share in the region increased significantly in the year,
above 12%3, vs. 11.8% in 2019. In Brazil, the brands combined also gained market share of 4 pp4 in the quarter,
and 0.6 pp4 in the year. This consolidates the Group’s clear leadership both in Latin America and in Brazil.
The Natura brand’s net revenue increased by 24.7% in BRL (+21.4% at CC), with strong +16.2% growth in Brazil. It
outperformed the domestic CFT market by almost 10 pp5 in Q4 and in the full year, driven by brand preference, continued
productivity improvement and acceleration in social selling. In Hispanic Latam, the Natura brand’s net revenue grew strongly
(+44.5% in BRL, +35.8% at CC) in all markets. The Avon brand’s net revenue increased by 16.2% in BRL (+3.9% at CC),
supported by improved representative productivity and the Home segment. Avon in Brazil grew for the second consecutive quarter,
up 4.9%, and Hispanic Latam returned to growth of +23.9% in BRL (+3.0% at CC). In FY20, Natura &Co Latam’s net
revenue increased by 9.4% in BRL (+3.7% at CC), with the Natura brand up +21.8% in BRL (+17.2% at CC) and the Avon brand down
-1.8% (-9.3% at CC).
|
|
·
|
Avon
International’s1 Q4 net revenue grew 12.1% in BRL (-11.5% at CC). Avon gained share in color, despite the
impact of the Covid-19 second wave in Avon’s key European markets, where core beauty categories declined. Highlights in
market share gains include the UK, which grew 3.0% at CC, and gained share for the 3rd consecutive quarter vs. the
previous year, and Russia, with sequential share improvement. In FY20, net revenue increased by 2.9% in BRL (-18.0% at CC).
|
|
·
|
The
Body Shop’s1 Q4
net revenue increased by 48.4% in BRL (+9.7%
at CC), driven by growth in the UK and Asia. Strong performance of At-Home (+206%) and e-commerce (+72%) more than offset the
impact of the pandemic’s second wave. FY20 net revenue increased 32.4% in BRL (stable at CC).
|
|
·
|
Aesop1
Q4 net revenue grew by exceptional
+62.1% in BRL (+19.3% at CC), driven by online sales growth of 190% vs. Q4-19. Asia’s remarkable performance was a highlight
in the quarter, driven by Japan and South Korea. In FY20, net revenue grew by 50.0% (+13.2% at CC), surpassing the half
billion Australian dollar mark.
|
|
·
|
Natura
&Co digital social selling and e-commerce sales continued to grow strongly, with total group digital sales (e-commerce
and social selling) up 79% in the quarter. In Q4 all brands recorded the highest-ever level of e-commerce sales. Aesop’s
total online sales reached almost 30% of its revenue, doubling over the previous year, and The Body Shop rapidly pivoted to online
and At-Home channels, which combined grew more than 130%, representing 40% of total sales. Social selling continues to grow, with
e-brochure revenue up nearly 90% vs. Q4-19 at Avon globally, and up 300% in the UK vs. prior year for the second consecutive quarter.
At Natura in Latin America, the number of consultants sharing content grew by more than 300% since Q1, e-brochure sales accounted
for one-third of total digital sales in the period and the number of orders through the 1 million+ consultant online stores in
the region increased by 60% vs. Q4-19.
|
|
·
|
Natura
&Co’s Q4 adjusted7 EBITDA was R$1,485.7 million with margin of 12.4% (-130 bps), primarily due to the
phasing of investments in brand, R&D and technology concentrated in Q4, after rigorous cost control steps taken in the first
half of the year to mitigate pandemic impacts. Reported EBITDA for Natura &Co was R$1,254.3 million (margin of 10.5%).
FY20 adjusted EBITDA was R$4,219.5 million, with a healthy margin of 11.4% (-80 bps), a strong result despite a challenging
year.
|
|
·
|
Natura
&Co Latam’s Q4 adjusted EBITDA margin was 12.2% (+120 bps). The Avon brand’s adjusted EBITDA margin increased
270 bps, thanks to revenue growth, operational leverage and synergies in both Brazil and Hispanic Latam, more than offsetting
the Natura brand’s 60 bps decrease in adjusted EBITDA margin, due to phasing of investments in brand, R&D and technology,
and FX pressure on COGS in Brazil. Q4 reported EBITDA margin was 11.3%. FY20 adjusted EBITDA margin was 11.9% (+150 bps).
|
|
·
|
Avon
International’s Q4 adjusted EBITDA margin stood at 4.1% (-560 bps), primarily due to foreign
currency impacts, lower revenue (at CC) and higher
strategic investments in brand, digital and commercial areas as part of our turnaround strategy to drive market share and accelerate
future growth . FY20 adjusted EBITDA margin was 5.2% (vs. 11.3% in FY19).
|
1
For comparison purposes, Q4-20 and Q4-19 results and analyses include: i) Q4-19 aggregated figures including Avon
Products, Inc. results in IFRS; ii) Natura &Co’s results in Latin America, which includes the operations of Avon, Natura,
The Body Shop and Aesop brands in the region; iii) the results of Avon International, The Body Shop and Aesop brands, except in
Latin America; iv) Q4-20 results and analyses including the effects of the fair market value assessment as a result of the business
combination with Avon as per the Purchase Price Allocation – PPA.
2
Cosmetics, Fragrance and Toiletries market performance: Company estimate based on global peers’ net revenue vs prior
year of approximately -0.4% in Q4and -8.3% in FY20 (in reported FX), as reported by the companies or estimates published on Bloomberg
for those who have not yet reported; Natura &Co Q4-20 growth of 6.4% (at CC) vs. -0.4% market = +6.4pp; Natura &Co FY20
revenue -2.3% (at CC) vs. -8.3% market = +6.0pp;
3
Source: Based on Company’s estimates for Latin America;
4
Source: Kantar;
5
Source: ABIHPEC of +6.3% in Q4 and +6.2% in FY20; Natura brand in Brazil Q4-20 revenue +16.3% vs. 6.3% market = +10 pp;
Natura FY20 revenue +16.5% vs. 6.2% market = +10.3 pp; According to Kantar, the market grew 6.4% in FY20;
6
Source: Kantar Household Panel.
7
Excluding effects that are not considered recurring nor comparable between the periods under analysis.
|
·
|
The
Body Shop’s Q4 adjusted EBITDA margin was 23.7% (-290 bps), mainly due to the pandemic’s impact on retail sales,
especially in Europe, as well as channel mix effects. FY20 adjusted EBITDA margin was 20.2% (-80 bps).
|
|
·
|
Aesop’s
Q4 adjusted and reported EBITDA margin reached an impressive 37.1% (+90 bps), driven by strong revenue growth, notably in
Asia, and cost discipline. FY20 EBITDA margin stood at 31.1% (+410 bps).
|
|
·
|
Net
profit significantly up by 200.1% in Q4, and underlying net income grew 47.5%, driven by higher EBITDA and lower income tax
expense. In FY-20, underlying net income was R$399.5 million and reported net income was R$(650.2) million, due to impact on activity
from the pandemic, Avon acquisition-related PPA and tax effects. Management will recommend to offset losses against capital reserves,
subject to approval by the extraordinary shareholders’ meeting on April 16.
|
|
·
|
Synergies
from the Avon integration of US$25.5 million in Q4, ahead of plan. The synergies achieved this quarter primarily relate to
administrative and procurement, incurring US$22.0 million in costs to achieve. In FY20 we achieved a total of US$73.3 million
in accumulated synergies and incurred US$37.7 million in costs to achieve, ahead of the guidance of 16% of planned synergies of
US$300 million to US$400 million, and US$72 million in costs to achieve.
|
|
·
|
Robust
cash position of R$8.3 billion and significant deleveraging: Consolidated net debt-to-EBITDA ratio of 0.97x. Natura
&Co completed a US$1 billion capital raise (R$5.6 billion) in the quarter and prepaid US$ 900 million in Avon bonds maturing
in 2022. These initiatives, combined with strong cash flow generation of R$ 1.0 billion in the period, resulted in a robust cash
position, allowing
for a strong deleveraging at Group level and ensuring compliance with our financial covenants.
|
|
·
|
ESG
Agenda: Update on our 2030 Sustainability Vision:
|
|
·
|
To
address the Climate Crisis: In 2020, the Natura brand avoided 32% in emissions, which is equivalent to 162,000 tons CO2e of
GHG; all four brands launched their plans to become Net Zero by 2030 on Scopes 1, 2 and 3;
|
|
·
|
To
defend Human Rights and to be Human-Kind: Natura &Co has invested nearly R$500 million in 2020 in key causes such as fighting
Covid-19, support to women, sourcing and benefit sharing with communities, among others;
|
|
·
|
To
embrace Circularity and Regeneration: Natura &Co replaced 2,489 tons of virgin plastic for recycled, equivalent to more
than 120 million PET bottles.
|
|
1.
|
Management commentary:
|
Roberto
Marques, Executive Chairman and CEO of Natura &Co, commented:
“2020
was a year that changed the world. A year that showed us how vulnerable and interdependent we all are, a year that has transformed
Natura &Co for the foreseeable future.
It
was a time to care and a time to adapt. A time to care, making the health and safety of our associates and of our network of consultants
and representatives our utmost priority and providing financial and workplace support to our workforce and business partners.
A time to adapt, as we rapidly pivoted across our brands to online sales and digital social selling when lockdowns across the
world temporarily shut down retail operations. We also quickly shifted production to essential products such as soaps and hand
sanitizers and mobilized significant donations across the world from our four brands.
This
agility allowed Natura &Co to post double-digit sales growth in the full year, significantly outperforming the global CFT
market both in the fourth quarter and the full year, delivering robust EBITDA and strengthening our balance sheet, notably through
two capital raisings totaling R$7.6 billion. This performance is testament to the incredible dedication of our teams across our
iconic brands around the world, who demonstrated throughout the year compassion and empathy, resilience and agility, determination
and boldness, and I would like to express my gratitude for their efforts and solid results. It is also a strong validation of
the Group’s omni-channel and multi-brand strategy, and a clear demonstration of Natura &Co’s purpose-driven approach,
nurturing beauty and relationships, even in a virtual world, for a better way of living and doing business.
This
extraordinary year, which began with us welcoming Avon into our family of iconic brands just as the pandemic began to spread,
actually accelerated many of our strategic initiatives and made us truly omnichannel. Our digital transformation became a reality,
with 79% growth in total digital sales across the Group, including e-commerce and social selling. We made further significant
strides in digitalization through our strategic partnership with Singu, and the launch of &Co Pay, our proprietary financial
services platform. We also took decisive steps towards geographic expansion in the past year, buying back The Body Shop’s
operations in Japan, launching At-Home in the U.S., and making further advances on entering China. And we launched our 2030 Commitment
to Life sustainability vision, a very comprehensive and ambitious plan to maximize our social and environmental impact over the
next 10 years and help build common standards to guide all who are committed to positive change.
The
fourth quarter provided a clear demonstration of the strength and resilience of our business and the power of our brands, and
we are very pleased with our results. All of our brands contributed to revenue growth, and our consolidated EBITDA margin remained
strong while reflecting phased investments in branding, R&D and technology to support continued sustainable growth. The Natura
brand continues to post double-digit growth both in Brazil and Latin America, boosted by a strong Christmas campaign, while the
Avon brand grew for the second consecutive quarter in Brazil and returned to growth in Hispanic Latam. The Body Shop quickly and
successfully switched to online and At-Home, which together grew 130%, and Aesop posted another stellar performance, accelerating
its e-commerce strategy, growing 190%, and benefitting from its geographic footprint and strong brand preference, notably in Asia.
The
integration of Avon has advanced well, with synergies materializing ahead of plan from initiatives in administrative, procurement
and manufacturing. We also initiated the Avon’s brand rejuvenation with the launch of impactful campaigns around the world,
reconnecting the brand with social causes it defends, such as fighting domestic violence and promoting gender equality and antiracism.
Despite the higher impact of Covid-19 in Europe and in key categories like makeup and fragrances, we are pleased to see market
share gains in the UK and sequential share improvement in Russia.
The
world is going through unprecedented times, and Natura &Co, as a purpose-driven group, is determined to continue to make positive
impact. Besides the launch of our 2030 Sustainability Vision, we have just been certified as a B-Corp as a Group, attesting to
our sustainable business practices. The Natura brand has reduced by 32% its carbon emissions, the Group replaced 2,500 tons of
virgin plastic for recycled plastic and invested nearly a half billion reais in key causes: the Amazon, breast cancer awareness,
the fight against domestic violence, public education and donations. As a beauty group, we know that women, in particular, are
key to making a difference and following the upcoming International Women’s Day we will detail our many initiatives to tackle
the gender gap. But to really make systemic change, we cannot act in isolation. It’s vital that we pull together as businesses
and as society as a whole to share experiences and solutions.
Finally,
as has been announced, José Filippo will be stepping down as Chief Financial Officer at the end of the year. We would like
to thank him for his leadership and strong contribution since he joined the Group. During that time, he played a leading role
in the acquisition of Avon in January 2020, which included listing Natura &Co both on the B3 and NYSE, managed the two successful
capital raises last year, implemented Natura &Co’s global financial structure and strengthened our internal controls
and liability management functions.
To
ensure a smooth transition, we are pleased to announce that Guilherme Castellan will be joining the Group as Deputy CFO in April.
He will work closely with José Filippo over the coming months and will become the Group CFO after Filippo completes his
cycle. A Brazilian national, Guilherme Castellan joins Natura &Co after seven years at AB InBev Group, where he held senior
financial positions in New York, Sao Paulo, Shanghai and Hong Kong. In his last position he was Chief Financial Officer at Budweiser
Brewing Co. APAC Ltd, a listed company based in Hong Kong. We are looking forward to welcoming him to the Group.”
The
Company is closely monitoring the evolution of the Covid-19 pandemic worldwide, particularly the recent new lockdown or restriction
measures adopted in parts of Europe. The Crisis Committee created in Q2 continuously analyzes the situation and acts to minimize
impacts, ensure continuity of operations, protect cash and improve liquidity. Natura &Co also continues to be attentive to
the health and safety of its employees, consultants and representatives and customers.
Key
impacts on the business
|
·
|
Lockdown
restrictions: In the fourth quarter, Natura &Co’s businesses were impacted by a second wave of the pandemic in certain
markets. The shift to digital continued across all our brands, allowing us to largely offset the impact of store closures, with
e-commerce sales across the group up 79% vs. Q4-19.
|
|
·
|
Natura
&Co Latam: All retail stores, including franchisee stores, were opened during the quarter, albeit under certain restrictions.
The adoption of digital assets by consultants continued to play an important role in their performance.
|
|
·
|
Avon
International: The company was highly impacted by two effects: i) stricter lockdowns across key markets, especially in Europe,
as well as the Philippines and South Africa, and ii) category mix: Greater dependence on beauty categories such as fragrances
and cosmetics, which were heavily hit. This was partly offset by the acceleration in the adoption of digital assets in key markets
such as the UK. Total net sales were +12.1% in BRL and down 11.5% at constant currency in Q4-20.
|
|
·
|
The
Body Shop: Retail sales were impacted in important markets by mandatory store closures, especially in Europe. With only 78%
of Company stores open in December, own-stores like-for-like sales decreased 17% vs. Q4-19. Strong performance in At Home (+206%)
and online (+72%) channels more than offset the pandemic’s effect. Total net sales grew 9.7% at constant currency in Q4-20.
|
|
·
|
Aesop:
The company was also impacted by the new lockdowns in Europe, where retail like-for-like sales were down 4.0%. The shift in
consumer behaviour to online more than offset this decrease and total net sales posted remarkable growth of 19.3% at constant
currency in the quarter. Aesop benefited from its greater presence in Asia, which accounts for the larger part of its business,
as the region was impacted earlier than Europe and reported a swifter recovery than other geographies.
|
For
comparison purposes, Q4-20 and Q4-19 results and analysis include the following:
|
·
|
The
effects of IFRS 16 in both periods
|
|
·
|
Q4-19
aggregated and adjusted (unaudited) results include Avon in IFRS and Latin America operations of The Body Shop and Aesop in the
Natura &Co Latam segment
|
|
·
|
The
Group segmentation composed of:
|
|
·
|
Natura
&Co Latam, which includes all the brands in Latin America: Natura, Avon, The Body Shop and Aesop
|
|
·
|
Avon
international, which includes all markets, excluding Latin America
|
|
·
|
The
Body Shop ex-Latin America, and
|
In
addition, Q4-20 results and analysis include the effects of the fair market value assessment as a result of the business combination
with Avon as per the Purchase Price Allocation – PPA.
|
Pró-Forma
|
|
|
Profit
and Loss by Business
|
R$
million
|
Consolidated
a
|
Natura
&Co Latam b
|
Avon
International
|
The
Body Shop
|
Aesop
|
Q4-20
c
|
Q4-19
d
|
Ch.
%
|
Q4-20
c
|
Q4-19
d
|
Ch.
%
|
Q4-20
c
|
Q4-19
d
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Gross
Revenue
|
15,260.7
|
12,863.5
|
18.6
|
8,294.7
|
7,117.5
|
16.5
|
3,406.2
|
3,151.0
|
8.1
|
2,741.7
|
2,094.4
|
30.9
|
818.2
|
500.5
|
63.5
|
Net
Revenue
|
11,997.3
|
9,654.5
|
24.3
|
6,320.6
|
5,244.8
|
20.5
|
2,868.5
|
2,558.8
|
12.1
|
2,075.9
|
1,399.2
|
48.4
|
732.3
|
451.8
|
62.1
|
COGS
|
(4,280.0)
|
(3,450.9)
|
24.0
|
(2,452.2)
|
(2,013.6)
|
21.8
|
(1,284.0)
|
(1,076.0)
|
19.3
|
(471.7)
|
(316.9)
|
48.9
|
(72.1)
|
(44.5)
|
62.2
|
Gross
Profit
|
7,717.2
|
6,203.6
|
24.4
|
3,868.5
|
3,231.2
|
19.7
|
1,584.5
|
1,482.8
|
6.9
|
1,604.2
|
1,082.3
|
48.2
|
660.1
|
407.3
|
62.1
|
Selling, Marketing and Logistics Expenses
|
(5,244.7)
|
(3,916.2)
|
33.9
|
(2,540.6)
|
(2,065.6)
|
23.0
|
(1,184.4)
|
(975.8)
|
21.4
|
(1,170.5)
|
(665.0)
|
76.0
|
(349.2)
|
(209.8)
|
66.4
|
Administrative, R&D, IT and Projects
Expenses
|
(1,619.1)
|
(1,312.1)
|
23.4
|
(717.6)
|
(748.3)
|
(4.1)
|
(502.1)
|
(299.4)
|
67.7
|
(286.9)
|
(176.8)
|
62.3
|
(110.5)
|
(87.7)
|
26.0
|
Corporate Expenses e
|
(171.3)
|
(75.8)
|
126.0
|
-
|
(18.1)
|
-
|
-
|
(18.9)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Other Operating Income/ (Expenses), Net
|
(18.8)
|
(39.2)
|
(51.9)
|
(10.8)
|
20.3
|
(153.2)
|
(3.9)
|
(40.1)
|
(90.3)
|
(4.7)
|
(18.4)
|
(74.3)
|
(0.9)
|
(0.9)
|
(2.0)
|
Acquisition Related Expenses f
|
-
|
(105.9)
|
-
|
-
|
-
|
-
|
-
|
(68.5)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Transformation/Integration costs
|
(87.0)
|
(124.1)
|
(29.9)
|
(57.5)
|
(11.4)
|
402.2
|
(20.7)
|
(94.0)
|
(78.0)
|
-
|
(18.7)
|
-
|
-
|
-
|
-
|
Depreciation
|
678.0
|
403.8
|
67.9
|
174.6
|
159.7
|
9.3
|
224.9
|
55.9
|
302.2
|
206.3
|
133.6
|
54.4
|
72.1
|
54.6
|
32.1
|
EBITDA
|
1,254.3
|
1,034.0
|
21.3
|
716.6
|
567.8
|
26.2
|
98.3
|
42.0
|
133.9
|
348.3
|
337.0
|
3.4
|
271.6
|
163.5
|
66.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
(678.0)
|
(403.8)
|
67.9
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Income/(Expenses), Net
|
(248.9)
|
(390.2)
|
(36.2)
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
Before Taxes
|
327.3
|
240.1
|
36.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxes on Holding Company Constitution
|
-
|
(206.6)
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax and Social Contribution
|
(82.0)
|
(209.6)
|
(60.9)
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations g
|
(69.7)
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Net Income
|
175.7
|
(176.1)
|
(199.8)
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-controlling Interest
|
1.7
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Income attributable to controlling shareholders
|
177.4
|
(176.1)
|
(200.7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Margin
|
64.3%
|
64.3%
|
0
bps
|
61.2%
|
61.6%
|
-40
bps
|
55.2%
|
57.9%
|
-270
bps
|
77.3%
|
77.4%
|
-10
bps
|
90.2%
|
90.2%
|
0
bps
|
Selling, Marketing and Logistics Exp./Net Revenue
|
43.7%
|
40.6%
|
310 bps
|
40.2%
|
39.4%
|
80 bps
|
41.3%
|
38.1%
|
320 bps
|
56.4%
|
47.5%
|
890 bps
|
47.7%
|
46.4%
|
130 bps
|
Admin., R&D, IT, and Projects Exp./Net Revenue
|
13.5%
|
13.6%
|
-10 bps
|
11.4%
|
14.3%
|
-290 bps
|
17.5%
|
11.7%
|
580 bps
|
13.8%
|
12.6%
|
120 bps
|
15.1%
|
19.4%
|
-430 bps
|
EBITDA Margin
|
10.5%
|
10.7%
|
-20 bps
|
11.3%
|
10.8%
|
50 bps
|
3.4%
|
1.6%
|
180 bps
|
16.8%
|
24.1%
|
-730 bps
|
37.1%
|
36.2%
|
90 bps
|
Net Margin
|
1.5%
|
(1.8)%
|
330
bps
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a
Consolidated results include Natura &Co Latam, Avon International, The Body Shop and Aesop, as well as the Natura
subsidiaries in the U.S., France and the Netherlands.
|
|
|
|
|
|
|
b Natura
&Co Latam: includes Natura, Avon, TBS Brazil and Hispanic Latam and Aesop Brazil
|
|
|
|
|
|
|
|
|
|
|
|
|
|
c Q4-20:
Includes PPA – Purchase Price Allocation effects
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
d Q4-19:
Does not include PPA effects
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
e Expenses
related to the management and integration of the Natura &Co Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
f
Avon-acquisition-related expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
g
Related to business separation at Avon North America
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pró-Forma
|
|
Profit
and Loss by Business
|
R$
million
|
Consolidated a
|
Natura
&Co Latam b
|
Avon
International
|
The
Body Shop
|
Aesop
|
FY-20
c
|
FY-19
d
|
Ch.
%
|
FY-20
c
|
FY-19
d
|
Ch.
%
|
FY-20
c
|
FY-19
d
|
Ch.
%
|
FY-20
|
FY-19
|
Ch.
%
|
FY-20
|
FY-19
|
Ch.
%
|
Gross
Revenue
|
47,696.9
|
43,452.5
|
9.8
|
27,584.6
|
25,344.1
|
8.8
|
10,891.5
|
10,926.2
|
(0.3)
|
7,042.5
|
5,736.5
|
22.8
|
2,178.3
|
1,445.8
|
50.7
|
Net
Revenue
|
36,922.0
|
32,942.2
|
12.1
|
20,542.3
|
18,770.0
|
9.4
|
9,097.4
|
8,843.7
|
2.9
|
5,332.9
|
4,028.7
|
32.4
|
1,949.3
|
1,299.9
|
50.0
|
COGS
|
(13,229.7)
|
(11,841.3)
|
11.7
|
(8,062.8)
|
(7,194.0)
|
12.1
|
(3,822.0)
|
(3,592.2)
|
6.4
|
(1,157.0)
|
(933.6)
|
23.9
|
(188.0)
|
(121.5)
|
54.7
|
Gross
Profit
|
23,692.3
|
21,100.9
|
12.3
|
12,479.6
|
11,575.9
|
7.8
|
5,275.4
|
5,251.6
|
0.5
|
4,175.9
|
3,095.0
|
34.9
|
1,761.4
|
1,178.3
|
49.5
|
Selling, Marketing and Logistics Expenses
|
(16,426.0)
|
(13,719.8)
|
19.7
|
(8,331.8)
|
(7,470.0)
|
11.5
|
(3,949.8)
|
(3,414.7)
|
15.7
|
(3,144.0)
|
(2,174.8)
|
44.6
|
(1,000.4)
|
(660.3)
|
51.5
|
Administrative, R&D, IT and Projects
Expenses
|
(5,583.9)
|
(4,528.0)
|
23.3
|
(2,607.0)
|
(2,614.3)
|
(0.3)
|
(1,710.0)
|
(930.7)
|
83.7
|
(837.9)
|
(631.1)
|
32.8
|
(425.2)
|
(351.9)
|
20.8
|
Corporate Expenses e
|
(379.7)
|
(268.5)
|
41.4
|
-
|
(74.0)
|
-
|
-
|
(67.6)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Other Operating Income/ (Expenses), Net
|
47.5
|
409.4
|
(88.4)
|
77.2
|
413.3
|
(81.3)
|
(13.8)
|
16.1
|
(185.9)
|
(20.0)
|
(19.3)
|
3.6
|
2.7
|
(0.8)
|
(454.5)
|
Acquisition Related Expenses f
|
(303.9)
|
(316.2)
|
(3.9)
|
-
|
-
|
-
|
-
|
(174.7)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Transformation/Integration costs
|
(256.7)
|
(601.2)
|
(57.3)
|
(123.0)
|
(204.1)
|
(39.7)
|
(100.9)
|
(345.6)
|
(70.8)
|
-
|
(51.5)
|
-
|
-
|
-
|
-
|
Depreciation
|
2,718.9
|
1,522.3
|
78.6
|
874.6
|
572.0
|
52.9
|
814.7
|
204.4
|
298.5
|
761.2
|
559.9
|
36.0
|
268.1
|
185.9
|
44.2
|
EBITDA
|
3,508.5
|
3,598.9
|
(2.5)
|
2,369.5
|
2,198.9
|
7.8
|
315.5
|
538.7
|
(41.4)
|
935.3
|
778.2
|
20.2
|
606.5
|
351.4
|
72.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
(2,718.9)
|
(1,522.3)
|
78.6
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Income/(Expenses), Net
|
(1,035.4)
|
(1,097.3)
|
(5.6)
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
Before Taxes
|
(245.8)
|
979.3
|
(125.1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxes on Holding Company Constitution
|
0.0
|
(206.6)
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax and Social Contribution
|
(274.7)
|
(599.6)
|
(54.2)
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations g
|
(143.1)
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
net income
|
(663.7)
|
173.0
|
(483.6)
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-controlling Interest
|
13.5
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income attributable to controlling shareholders
|
(650.2)
|
173.0
|
(475.8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Margin
|
64.2%
|
64.1%
|
10
bps
|
60.8%
|
61.7%
|
-90
bps
|
58.0%
|
59.4%
|
-140
bps
|
78.3%
|
76.8%
|
150
bps
|
90.4%
|
90.7%
|
-30
bps
|
Selling, Marketing and Logistics Exp./Net Revenue
|
44.5%
|
41.6%
|
290 bps
|
40.6%
|
39.8%
|
80 bps
|
43.4%
|
38.6%
|
480 bps
|
59.0%
|
54.0%
|
500 bps
|
51.3%
|
50.8%
|
50 bps
|
Admin., R&D, IT, and Projects Exp./Net Revenue
|
15.1%
|
13.7%
|
140 bps
|
12.7%
|
13.9%
|
-120 bps
|
18.8%
|
10.5%
|
830 bps
|
15.7%
|
15.7%
|
0 bps
|
21.8%
|
27.1%
|
-530 bps
|
EBITDA Margin
|
9.5%
|
10.9%
|
-140 bps
|
11.5%
|
11.7%
|
-20 bps
|
3.5%
|
6.1%
|
-260 bps
|
17.5%
|
19.3%
|
-180 bps
|
31.1%
|
27.0%
|
410 bps
|
Net Margin
|
(1.8)%
|
0.5%
|
-230
bps
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
a
Consolidated results include Natura &Co Latam, Avon International, The Body Shop and Aesop, as well as the Natura
subsidiaries in the U.S., France and the Netherlands.
|
b Natura
&Co Latam: includes Natura, Avon, TBS Brazil and Hispanic Latam and Aesop Brazil
|
c FY-20:
Includes PPA – Purchase Price Allocation effects
|
d FY-19:
Does not include PPA effects
|
e Expenses
related to the management and integration of the Natura &Co Group
|
f
Avon-acquisition-related expenses
|
g
Related to business separation at Avon North America
|
Consolidated
net revenue growth in Q4-20 and FY-20
Q4-20
consolidated net revenue in BRL increased by 24.3% year-on-year (+6.4% at CC), driven by growth across all segments. In
FY-20, net revenue increased by 12.1% in BRL (-2.3% at CC) vs. FY-19.
|
·
|
Natura
&Co Latam: Net revenue rose by 20.5% in BRL in Q4 (+13.0% at CC)
|
|
·
|
Avon
International: Net revenue increased 12.1% in BRL in Q4 (-11.5% at CC)
|
|
·
|
The
Body Shop: Net revenue increased 48.4% in BRL in Q4 (+9.7% at CC)
|
|
·
|
Aesop:
Net revenue growth of 62.1% in BRL in Q4 (+19.3% at CC)
|
Gross
margin
Including
PPA effects in Q4-20 at Natura &Co Latam and Avon International
R$
million
|
Consolidated
|
Natura
&Co Latam
|
Avon
International
|
The
Body Shop
|
Aesop
|
Q4-20
a
|
Q4-19
b
|
Ch.
%
|
Q4-20
a
|
Q4-19
b
|
Ch.
%
|
Q4-20
a
|
Q4-19
b
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Net
Revenue
|
11,997.3
|
9,654.5
|
24.3
|
6,320.6
|
5,244.8
|
20.5
|
2,868.5
|
2,558.8
|
12.1
|
2,075.9
|
1,399.2
|
48.4
|
732.3
|
451.8
|
62.1
|
COGS
|
(4,280.0)
|
(3,450.9)
|
24.0
|
(2,452.2)
|
(2,013.6)
|
21.8
|
(1,284.0)
|
(1,076.0)
|
19.3
|
(471.7)
|
(316.9)
|
48.9
|
(72.1)
|
(44.5)
|
62.2
|
Gross
Profit
|
7,717.2
|
6,203.6
|
24.4
|
3,868.5
|
3,231.2
|
19.7
|
1,584.5
|
1,482.8
|
6.9
|
1,604.2
|
1,082.3
|
48.2
|
660.1
|
407.3
|
62.1
|
Gross Margin
|
64.3%
|
64.3%
|
0
bps
|
61.2%
|
61.6%
|
-40
bps
|
55.2%
|
57.9%
|
-270
bps
|
77.3%
|
77.4%
|
-10
bps
|
90.2%
|
90.2%
|
0 bps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a Q4-20
includes PPA – Purchase Price Allocation effects
|
|
|
|
|
|
|
|
|
|
|
|
|
|
b Q4-19
does not include PPA – Purchase Price Allocation effects
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
gross margin in Q4 was stable at 64.3%. Excluding PPA effects on COGS of -R$23.2 million (+R$5.0 million at Natura &Co Latam;
-R$28.2 million at Avon International), adjusted consolidated gross margin reached 64.5% in Q4-20 (+20 bps), as shown below:
Without
PPA effects in both periods
R$
million
|
Consolidated
|
Natura
&Co Latam
|
Avon
International
|
The
Body Shop
|
Aesop
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Q4-20
|
Q4-19
|
Ch.
%
|
Net
Revenue
|
11,997.3
|
9,654.5
|
24.3
|
6,320.6
|
5,244.8
|
20.5
|
2,868.5
|
2,558.8
|
12.1
|
2,075.9
|
1,399.2
|
48.4
|
732.3
|
451.8
|
62.1
|
COGS
|
(4,256.9)
|
(3,450.9)
|
23.4
|
(2,457.1)
|
(2,013.6)
|
22.0
|
(1,255.9)
|
(1,076.0)
|
16.7
|
(471.7)
|
(316.9)
|
48.9
|
(72.1)
|
(44.5)
|
62.2
|
Gross
Profit
|
7,740.4
|
6,203.6
|
24.8
|
3,863.5
|
3,231.2
|
19.6
|
1,612.6
|
1,482.8
|
8.8
|
1,604.2
|
1,082.3
|
48.2
|
660.1
|
407.3
|
62.1
|
Gross
Margin
|
64.5%
|
64.3%
|
20
bps
|
61.1%
|
61.6%
|
-50
bps
|
56.2%
|
57.9%
|
-170
bps
|
77.3%
|
77.4%
|
-10
bps
|
90.2%
|
90.2%
|
0
bps
|
|
·
|
Natura
&Co Latam’s adjusted gross margin was 61.1% in Q4-20 (-50 bps), due mainly to foreign currency impacts at Natura
and Avon brands in Brazil and Avon in Hispanic Latam, partially offset by increased gross margin at Natura brand in Hispanic Latam
|
|
·
|
Avon
International’s adjusted gross margin was 56.2% in Q4-20 (-170 bps), mainly due to foreign currency impact, notably
from Turkey, Middle East and Africa, and cost pressure on COGS
|
|
·
|
The
Body Shop’s gross margin stood at 77.3% in Q4-20, virtually stable vs. last year.
|
|
·
|
Aesop’s
gross margin was stable at 90.2%
|
Consolidated
EBITDA
Reported
EBITDA was R$1,254.3 million in Q4-20 with margin of 10.5% (-20 bps vs. Q4-19). Adjusted EBITDA was R$1,485.7 million, with an
adjusted margin of 12.4% (-130 bps), excluding transformation costs and impairment of certain stores at The Body Shop, impacted
by phased investments in brand, R&D and technology, which were concentrated in Q4 after rigorous cost control steps taken
in the first half of the year. FY20 reported EBITDA was R$3,508.5 million, with margin of 9.5% (-140 bps), and adjusted
EBITDA was R$4,219.5 million, with margin of 11.4% (-80 bps), reflecting pandemic effects on revenue causing operational deleverage.
See reconciliation below:
|
|
Consolidated EBITDA
|
|
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
|
|
Consolidated EBITDA
|
1,254.3
|
1,034.0
|
21.3
|
3,508.5
|
3,598.9
|
(2.5)
|
|
Transformation/Integration costs (1)
|
87.0
|
124.1
|
(29.9)
|
256.7
|
601.2
|
(57.3)
|
|
Avon acquisition-related expenses (2)
|
-
|
105.9
|
-
|
303.9
|
316.1
|
(3.9)
|
|
Tax credits, recoveries and provision reversal (3)
|
-
|
-
|
-
|
(97.0)
|
(399.1)
|
(75.7)
|
|
Assets sale (4)
|
-
|
-
|
-
|
-
|
(197.1)
|
-
|
|
Impairment loss on assets and other items (5)
|
144.5
|
58.9
|
145.4
|
144.5
|
96.4
|
49.9
|
|
Non-recurring PPA impacts on EBITDA (6)
|
-
|
-
|
-
|
102.9
|
-
|
-
|
|
Adjusted EBITDA
|
1,485.7
|
1,323.0
|
12.3
|
4,219.5
|
4,016.4
|
5.1
|
|
Adjusted EBITDA Margin
|
12.4%
|
13.7%
|
-130 bps
|
11.4%
|
12.2%
|
-80 bps
|
|
(1)
|
Transformation/Integration costs: Includes integration
costs at Natura &Co Latam (costs to achieve synergies), Avon’s Open-Up and Grow costs at Avon International in both
years, and The Body Shop in Q4-19
|
|
(2)
|
Avon acquisition-related expenses: Non-recurring costs
associated with Avon acquisition, in Q4-19
|
|
(3)
|
Tax credits, recoveries and provision reversal: In
FY20 refers to non-recurring provision reversal on social charges at Natura, and Pis and Cofins tax credits at Avon in Brazil.
In FY19 refers to non-recurring tax recoveries from previous years, related to ICMS taxes applied on the base of Pis and Cofins
taxes at Avon in Brazil
|
|
(4)
|
Asset sale: Gain on sale of Avon North America (New
Avon) in 2019, in which Avon Products, Inc. held a 19.9% interest
|
|
(5)
|
Impairment loss on assets and other items: R$144.5
million in Q4-20 in impairment loss at The Body Shop, related to loss-making legacy stores, predominantly in the US, that were
previously included in the store closure plan and were further impacted by pandemic effects. In Q4-19 the effects relate to miscellaneous
items at Avon International and a write-off of intangible assets at The Body Shop
|
|
(6)
|
Non-recurring inventory PPA impacts in FY20: Relate
to non-cash adjustments to Avon’s opening balance sheet, resulting from transactions that occurred in 2019
|
Financial
income and expenses
Net
financial expenses were R$248.9 million in Q4-20, a reduction of 36.2% vs. Q4-19, mainly driven by the prepayment of Avon’s
2022 bonds on November 2, 2020 of US$900 million, which resulted in lower interest expense and a positive PPA effect. The quarter
also saw lower interest rates in Brazil and net gains on swaps and derivatives, partially offset by financial transaction fees
related to the prepayment of Avon bonds and other effects (recorded in “other” below).
The
following table details the main changes in our financial income and expenses:
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
1. Borrowings & Financing, ST Investments and Op. FX Gains/Losses
|
69.0a
|
(243.6)
|
(128.3)
|
(501.8)
|
(863.5)
|
(41.9)
|
2. Judicial Contingencies
|
(3.1)
|
23.4
|
(113.4)
|
26.8
|
217.7
|
(87.7)
|
3. Other Financial Income and Expenses
|
(314.8)
|
(170.0)
|
85.2
|
(560.4)
|
(451.5)
|
24.1
|
Lease Interest Expenses
|
(52.9)
|
(52.2)
|
1.4
|
(229.5)
|
(198.4)
|
15.7
|
Other
|
(261.9)
|
(117.8)
|
122.3
|
(330.8)
|
(253.2)
|
30.7
|
Financial Income and Expenses, Net
|
(248.9)
|
(390.2)
|
(36.2)
|
(1,035.4)
|
(1,097.3)
|
(5.6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a. Includes positive PPA impact of R$209.4 million, mainly related to the prepayment of Avon’s 2022 bonds
|
|
|
Underlying
Net Income (UNI)
Underlying
Net Income was R$249.3 million in Q4, up 47.5% vs. last year, before Avon acquisition-related effects of R$72.0 million, which
include: i) transformation costs of R$87.0 million and ii) discontinued operations expenses of R$31.9 million, offset by iii)
PPA amortization effect of R$45.2 million and iv) non-controlling interests of R$1.7 million.
Reported
net income in Q4 was R$177.4 million, reversing a loss of R$176.1 million in Q4-19, driven by higher EBITDA and lower income tax
expense of R$332.7 million vs. Q4-19, partially offset by higher depreciation of R$146.3 million and higher financial expenses
of R$183.2 million. Lower income tax expense was driven mainly by tax offsets against Avon’s losses in the UK in the quarter
and a non-recurring tax effect in Q4-19 of R$206.6 million related to the constitution of the holding company. In FY-20, underlying
net income was R$399.5 million and reported net income was R$(650.2) million, due to impact on activity from the pandemic, Avon
acquisition-related PPA and tax effects. Management will recommend to offset losses against capital reserves, subject to approval
by the extraordinary shareholders’ meeting, to be held on April 16.
a)
Income tax and taxes on holding company constitution
b)
Other includes non-controlling interest and discontinued operations
c)
Net income attributable to controlling shareholders
Free
cash flow and cash position
We
ended the quarter with a strong cash position of R$8.3 billion (R$5.8 billion in cash, and R$2.5 billion in short-term deposits),
post the US$900 million 2022 Avon bond prepayment in November, in
line with projections and well above our minimum thresholds.
The
strong cash flow generation of R$1.0 billion in Q4 helped reverse negative cash flow in the first half of the year, despite Avon
acquisition costs and Covid-19 impacts. Cash generation in Q4-20 was driven by strong operational results and improvement in working
capital, mainly lower inventory at Natura &Co Latam and extended payables at The Body Shop, notably rent deferrals.
|
|
|
|
|
|
|
R$ million
|
Q4-20
|
Q4-19 c
|
Ch. %
|
FY-20
|
FY-19 c
|
Ch. %
|
Net Income (Loss) Reported a
|
177.4
|
(176.1)
|
(200.7)
|
(650.2)
|
173.0
|
(475.8)
|
Depreciation and Amortization
|
678.0
|
403.8
|
67.9
|
2,718.9
|
1,522.3
|
78.6
|
Non-Cash/Others b
|
(609.1)
|
654.2
|
(193.1)
|
(1,296.0)
|
(37.7)
|
3,340.5
|
Internal Cash Generation
|
246.3
|
881.8
|
(72.1)
|
772.7
|
1,657.6
|
(53.4)
|
Working Capital Decrease / (Increase)
|
1,159.7
|
719.5
|
61.2
|
48.3
|
(481.3)
|
(110.0)
|
Cash Generation (Use) Before Capex
|
1,406.0
|
1,601.3
|
(12.2)
|
821.0
|
1,176.4
|
(30.2)
|
Capex
|
(376.4)
|
(264.3)
|
42.4
|
(790.7)
|
(801.7)
|
(1.4)
|
Sale of Assets
|
-
|
24.7
|
-
|
-
|
417.5
|
-
|
Free Cash Flow
|
1,029.5
|
1,361.7
|
(24.4)
|
30.2
|
792.1
|
(96.2)
|
|
|
|
|
|
|
|
a Attributable to the owners of the Company
|
|
|
|
b Includes the effects of deferred income tax, fixed and intangible assets write-offs, FX on translation of working capital, fixed assets, etc.
|
c 2019 numbers are on an aggregated, estimated and non-audited basis
|
|
|
|
Capital
structure and liquidity
In
the quarter, the Group successfully concluded an SEC-registered global follow-on offering of US$1 billion (R$5.6 billion), through
the issuance of 121.4 million common shares, subscribed by existing shareholders and new investors, with partial placement in
the form of American Depositary Shares (ADSs), adding liquidity to the program.
On
November 2nd, 2020 we prepaid the US$900 million Avon 2022 bonds in the amount equivalent to 101.969% plus accrued
interest until that date, as well as repaid the promissory note of R$560 million at holding Company level, related to the Avon
acquisition.
Strong
deleveraging at both Natura Cosméticos and Natura &Co Holding
Natura
&Co Holding’s consolidated net debt-to-EBITDA stood at 0.97x in Q4-20, significantly
down from 2.17x in Q4-19, including the effects of IFRS 16 (excluding IFRS 16: 1.16x in Q4-20 vs. 2.62x in Q4-19).
Natura
Cosméticos’ net debt-to-EBITDA stood at 0.68x in Q4-20, down from 1.92x in Q4-19, including the effects of IFRS 16
(excluding IFRS 16: 0.90x in Q4-20, down from 2.49x in Q4-19, significantly below pre The Body Shop acquisition levels).
|
Natura Cosméticos S.A.
|
Natura &Co Holding S.A.
|
R$ million
|
Q4-20
|
Q4-19
|
Q4-20
|
Q4-19
|
Short-Term
|
3,062.5
|
471.0
|
3,805.6
|
3,527.2
|
Long-Term
|
6,065.3
|
7,432.0
|
9,567.6
|
13,870.6
|
Gross Debt a
|
9,127.8
|
7,903.0
|
13,373.2
|
17,397.8
|
Foreign currency hedging (Swaps) b
|
(1,625.8)
|
(662.1)
|
(1,625.8)
|
(662.1)
|
Total Gross Debt
|
7,501.9
|
7,240.9
|
11,747.4
|
16,735.7
|
(-) Cash, Cash Equivalents and Short-Term Investment
|
(5,151.0)
|
(2,488.7)
|
(8,342.3)
|
(8,935.3)
|
(=) Net Debt
|
2,350.9
|
4,752.2
|
3,405.0
|
7,800.4
|
|
|
|
|
|
Indebtedness ratio excluding IFRS 16 effects
|
|
|
|
|
Net Debt/EBITDA
|
0.90x
|
2.49x
|
1.16x
|
2.62x
|
Total Debt/EBITDA
|
2.86x
|
3.80x
|
4.01x
|
5.63x
|
|
|
|
|
|
Indebtedness ratio including IFRS 16 effects
|
|
|
|
|
Net Debt/EBITDA
|
0.68x
|
1.92x
|
0.97x
|
2.17x
|
Total Debt/EBITDA
|
2.17x
|
2.93x
|
3.35x
|
4.65x
|
|
|
|
|
|
a Gross debt excludes PPA impacts of R$449.7 million and excludes lease agreements
|
|
|
b Foreign currency debt hedging instruments, excluding mark-to-market effects
|
|
|
|
|
4.
|
Performance by segment
|
Natura
&Co Latam1: The Natura brand posts strong double-digit growth; The Avon brand grows for the second consecutive
quarter in Brazil and resumes growth in Hispanic Latam
Net
revenue at Natura &Co Latam increased by 20.5% in Q4-20 in BRL (+13.0% at CC), driven by the Natura brand‘s strong 24.7%
growth (+16.2% Brazil, +44.5% Hispanic Latam), while the Avon brand was up 16.2% (+4.9% in Brazil, +23.9% in Hispanic Latam).
The combined brands in Latin America gained significant market share in the year, consolidating
the Group’s clear leadership in the region with over 12% market share, vs. 11.8% in 2019. In Brazil, the brands combined
also strengthened market leadership, with market share gains of 4 pp in the quarter, and 0.6 pp in the year. The
Natura brand’s performance, both in Brazil and Hispanic Latam, attests to the strength of our digital social selling model
on the back of successful Christmas campaigns and a strong innovation pipeline. The Avon brand’s improving trends continued,
with revenue growth in Brazil for the second consecutive quarter and a return to growth in Hispanic Latam, including Mexico, its
largest single market, as the digital transformation in the region continued. The satisfaction index for Avon representatives
in Brazil and Mexico remained strong, even after having reached its highest levels in the last 10 years, driven by aligning commercial
practices and continued improved communication as well as social and commercial support. Natura consultant loyalty index in Brazil
reached the best-ever level.
The
Avon integration in Latam is on track, with important progress in procurement, customer service, financial services, manufacturing,
logistics and digital. We launched a new e-commerce platform in Argentina, and implemented digital representative recruitment
and CRM initiatives. We unified the credit engine for the Natura and Avon brands in Latam, initiating pilots in various countries,
with rollout planned for early 2021. We began piloting multiple orders at any given time for Avon representatives in Brazil, to
complement the traditional one order per cycle system, and combined distribution sites and same vehicle delivery for Natura and
Avon boxes, optimizing freight. There were strong savings in procurement, despite Covid-19 impacts, and we implemented actions
to minimize raw materials and packaging constraints and foreign currency while optimizing working capital.
The
Natura brand in Brazil had a strong quarter, with significant market share gains, supported by continued brand preference and
a successful Christmas campaign. Our innovation index increased significantly vs. prior year, reaching 67.1% (+870 bps), the highest
in the last five years. This increase was driven by the successful relaunch of hero brands such as Tododia, Mamãe e Bebê,
Essencial and Biografia, and also important launches in fragrances such as Natura Homem Emocion.e, Luna Absoluta and Kayak Oceano,
which performed particularly well on festive dates. Volumes increased, mainly driven by
growth in core categories such as fragrances, body care, soaps and deodorants. Growth was also
supported by higher consultant activity level and a bigger consultant base. Productivity
per consultant grew for the 17th consecutive quarter, by +1.4% in Q4-20. The average available consultant base was
up 12.9% vs. Q4-19 (and +2.5% vs Q3-20), reaching 1.2 million consultants. We saw continued progression toward the top tier segments
(Silver, Gold and Diamond). Product launches in Brazil include new fragrances such as Essencial Mirra and Essencial Stilo for
men and women and a new men’s fragrance Natura Homem Verse; in makeup, a new Una Luz metallic collection; and in body care,
Tododia seasonal summer products such as Tododia Lima and Flor de Laranjeira and Ekos Buriti.
|
|
Avon’s
net revenue in Brazil grew 4.9% in Q4-20 vs. Q4-19, mainly driven by higher representative productivity, higher activity level
and a stable average number of representatives. Fashion & Home category sales grew double-digit and Avon focused on “above
the mask” make-up products. Brazil had strong innovation driven by fragrances, notably Segno, Aquavibe and Black Suede,
and the Color Trend nail polish line grew for the first time since Q1-18 in Brazil. Avon
launches in Brazil in the quarter included new shades across all face makeup products, covering the full diversity of Brazilian
skin tones. In Hispanic Latam, Natura launched Tododia Mango and Coconut Water with prebiotic nutrition, replicating the successful
launch in Brazil in Q3-20. Avon intensified media investments, with the launch of an antiracist
manifest and a campaign for a make-up line for black skin.
1
Natura &Co Latam is comprised of the Latin American operations of all the Group’s brands: Natura, Avon, The Body Shop
and Aesop. For comparison purposes, 2019 results include aggregated and adjusted (unaudited) information in IFRS to reflect this
new segment.
During
the year, the Avon brand in Brazil developed actions to increase the brand’s perception as giftable. Considerable advances
were made and gifting will continue to be a focus going forward, with a greater presence of best sellers and innovation in gifts.
The pilot of the new commercial model, to be rolled out in Q1/Q2-21, was completed.
The
Natura brand in Hispanic Latam posted a strong revenue increase of 44.5% in Q4-20 in BRL (+35.8% at CC), supported by growth in
all markets, notably Argentina, Chile and Mexico, with productivity increases and an expansion of the consultant
base (+16.1%), which reached 814,000. The quarter ended with a significantly higher consultant loyalty index in the region.
The
Avon brand in the Hispanic Latam returned to growth, of +23.9% in Q4-20 in BRL (+3.0% at CC).
The region saw improving trends towards the end of Q3, which continued throughout Q4, notably
Argentina, Chile and Mexico, with a sequential increase in the number of representatives. Certain markets in Hispanic Latam successfully
launched gift sets for the first time.
The
use of digital assets was fundamental for our business and consultants. The number of Natura
consultants trained on digital tools continued to increase vs. last year, and, as a result, there has been a continuous increase
in adoption. The interactive e-brochure continued to gain penetration and has allowed us to significantly grow sales through our
digital platforms, notably in Argentina. We launched a gift dedicated section in the Natura app for consultants, with the objective
of offering consultants and consumers gifts all year long. At the end of Q4 we neared 1.1 million Natura consultant online stores,
49% more than in Q4-19, with a significant year-on-year increase in the number of orders (over 40%) and visits (over 50%). At
Avon, e-brochure sales gained relevance and continued
to post significant growth, of 59% in Brazil in Q4, and the number of consumer visits to the e-brochure reached an average of
3.1 million per month.
In
the retail channel, all our Natura and The Body Shop stores operated with continued restrictions. We ended the quarter with over
700 stores, including 70 Natura own stores, over 140 The Body Shop stores and over 500 Natura franchised stores. The
expansion of our multichannel model has offered consumers a superior shopping experience, increasing touch points and consequently
increasing the number of new consumers. Leveraging on Natura’s digital platform, The Body Shop in Brazil launched a new
e-commerce site, significantly improving customer experience.
We
launched the &Co Pay platform in Q3, and in Q4 we initiated the rollout for the Natura brand in Brazil, (Natura Pay). We were
able to create a seamless experience for consultants and have seen substantial adoption. The next step in the roadmap will be
to launch this platform for Avon representatives, under the name of Avon Pay, in Q1-21, which will help drive productivity by
allowing them to make or receive payments and transfers through a digital account, while benefiting from many other financial
services, including debit and credit cards, loans, microcredit and loyalty programs. &Co Pay is also an enabler to promote
digital and financial inclusion to our consultants and reps. This is a scalable model in which we orchestrate the payment platform
supported by four licensed partners.
Natura
&Co Latam: Financial analysis
Reported
EBITDA was R$716.6 million with margin of 11.3% (+50 bps). Adjusted EBITDA, excluding transformation costs, was R$774.1 million
vs. R$579.2 million in Q4-19, with adjusted EBITDA margin of 12.2% (+120 bps), thanks to strong revenue growth and operational
leverage at both Natura and Avon. In FY20, reported EBITDA was R$2,369.5 million and EBITDA margin was 11.5% (-20 bps).
Adjusted EBITDA was R$2,437.8 million and adjusted EBITDA margin was 11.9% (+150 bps).
A
reconciliation between EBITDA and adjusted EBITDA is presented below:
|
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
|
|
EBITDA
|
716.6
|
567.8
|
26.2
|
2,369.5
|
2,198.9
|
7.8
|
|
Tax credits, recoveries and provision reversal
|
-
|
-
|
-
|
(97.0)
|
(399.1)
|
(75.7)
|
|
Transformation/Integration costs
|
57.5
|
11.4
|
402.2
|
123.0
|
204.1
|
(39.7)
|
|
Assets sale
|
-
|
-
|
-
|
-
|
(59.3)
|
-
|
|
Non-recurring PPA impacts on EBITDA
|
-
|
-
|
-
|
42.3
|
-
|
-
|
|
Impairment loss on assets and other items
|
-
|
-
|
-
|
-
|
4.6
|
-
|
|
Adjusted EBITDA
|
774.1
|
579.2
|
33.6
|
2,437.8
|
1,949.2
|
25.1
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin
|
12.2%
|
11.0%
|
120 bps
|
11.9%
|
10.4%
|
150 bps
|
Excluding
PPA effects on SG&A expenses, Selling, Marketing & Logistics expenses represented 39.9% of net revenue (+50 bps), due
to phasing of investments across brands, R&D and technology for continued sustainable growth.
Excluding
PPA effects, Administrative, R&D, IT and Project Expenses reached 11.6% of net revenue (-270 bps) in the quarter, largely
driven by net revenue growth at both brands and higher productivity across businesses.
R$
million
|
Q4-20
|
PPA
impacts
|
Q4-20
ex-PPA
|
Q4-19
|
Ch.
%
ex-PPA
|
FY-20
|
PPA
impacts
|
FY-20
ex-PPA
|
FY-19
|
Ch.
%
ex-PPA
|
Selling, Marketing
and Logistics Expenses
|
(2,540.6)
|
(16.9)
|
(2,523.7)
|
(2,065.6)
|
22.2
|
(8,331.8)
|
(126.1)
|
(8,205.8)
|
(7,470.0)
|
9.8
|
Administrative,
R&D, IT and Projects Expenses
|
(717.6)
|
18.7
|
(736.3)
|
(748.3)
|
(1.6)
|
(2,607.0)
|
37.2
|
(2,644.2)
|
(2,614.3)
|
1.1
|
SG&A
Expenses
|
(3,258.2)
|
1.8
|
(3,260.0)
|
(2,813.9)
|
15.9
|
(10,938.9)
|
(88.9)
|
(10,849.9)
|
(10,084.3)
|
7.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
Marketing and Logistics Exp./ Net Revenue
|
40.2%
|
-
|
39.9%
|
39.4%
|
50
bps
|
40.6%
|
-
|
39.9%
|
39.8%
|
10
bps
|
Admin.,
R&D, IT, and Projects Exp./ Net Revenue
|
11.4%
|
-
|
11.6%
|
14.3%
|
-270
bps
|
12.7%
|
-
|
12.9%
|
13.9%
|
-100
bps
|
Avon
International: Growth in the UK for the first time in a decade; improving fundamentals
Avon
started Q4 with improving trends, but revenue was impacted by the second wave of the pandemic, resulting in heightened restrictions,
especially in Central and Eastern Europe, which have been more severely hit. Average active representatives improved sequentially
(+11.4% vs. Q3-20) as a result of recovery actions, despite new lockdowns in several markets, but declined 7.3% vs Q4-19. Avon
International gained market share in color in the quarter, driven by key markets where beauty categories declined. In Russia,
market share improved sequentially since Q2 and the Philippines posted strong share gain in
fragrance in the quarter. The U.K. was again a highlight, posting growth vs. Q4 last year
for the first time in a decade, supported by growth in skin and body care, and gaining market share for the third consecutive
quarter, driven by the color category. Average sales and units sold per representative increased over prior year in Western Europe
and APAC, while continuing to reduce discounts.
Net
revenue grew 12.1% in Q4-20 and was down -11.5% at CC, with several key markets impacted by the second wave of Covid-19. Units
sold declined 17.6% vs. Q4-19, while showing a sequential improvement since the strong pandemic impacts in Q2. Beauty categories
were more impacted, as were Christmas-related purchases.
Avon
continued to take action to strengthen fundamentals, simplifying the commercial model by shifting to a new earnings structure
and reducing to monthly campaigns across all markets by the end of 2020, ahead of plan, which will harmonize planning and reduce
costs. In the quarter, Avon’s new visual identity was fully deployed across brochures and
digital content. The Avon brand’s social media reach and positive mentions (ex-Latam) were both 10 pp higher than in Q3-20,
driven by the Watch Me Now campaign. The roadmap foresees different phases for this campaign,
including representatives’ stories and content to be launched in early 2021. Avon Worldwide
channels have reached 14 million people in Q4 and gathered a community of 21 million Facebook followers across all markets. The
pilot for the new representative segmentation model started in South Africa, building on learnings from Natura.
In
terms of progress on integration, there are now multiple examples of the Group leveraging Avon’s supply chain, beyond the
rapid retooling of operations that took place during Covid-19 to produce essential products for the Group. Avon’s Poland
manufacturing facility successfully completed the pilot to produce Body Butter, one of The Body Shop’s most iconic products,
with production to be initiated in 2021.
Engagement
across the suite of Avon digital tools increased vs the prior year, as measured by revenues, traffic and adoption. During the
quarter, Avon launched the first ever digital Foundation Finder, piloting in e-commerce in South Africa.
Digital
performance accelerated in the quarter, with digital sales and AvonOn adoption increasing by approximately 100% vs. prior year
and growth in all markets. In the UK, the number of active representatives who used the AvonOn platform at least once a month
doubled to reach over 60% in Q4-20, and the number of active representatives sharing content and e-brochures nearly tripled vs.
Q4-19. E-brochure sales were up by nearly 300% in Q4 vs. prior year.
Launches
in the quarter included breakthrough innovation in hero skin care line Anew, now powered by Protinol™, a scientific discovery
made by Avon which accelerates collagen production. In color, the Sparkle lipstick in the Pearlesque collection gained the first
ever augmented filter, with double-digit growth in key markets, and the Glowing for Gold eyeshadow palette posted high double-digit
growth across all markets.
Net
revenue of the Avon brand, including Latin America and Avon International, grew 14.1% in BRL in Q4 (-4.5% at CC). In FY20, revenue
grew 0.4% in BRL (-14.5% at CC).
Avon
International: Financial analysis
Avon
International’s reported EBITDA was R$98.3 million in Q4-20 and adjusted EBITDA was R$118.9 million. Reported EBITDA margin
was 3.4% and adjusted EBITDA margin was 4.1% (-560 bps), due to the impact of lower revenue (-11.5% at CC), foreign currency impacts
as well as higher strategic investments in brand, digital and commercial areas to accelerate future growth.
In FY20, reported EBITDA was R$315.5 million and EBITDA margin was 3.5%. Adjusted
EBITDA was R$477.1 million and adjusted EBITDA margin was 5.2% (-610 bps).
A
reconciliation between EBITDA and adjusted EBITDA is presented below:
|
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
|
|
EBITDA
|
98.3
|
42.0
|
133.9
|
315.5
|
538.7
|
(41.4)
|
|
Transformation/Integration costs
|
20.7
|
94.0
|
(78.0)
|
100.9
|
345.6
|
(70.8)
|
|
Assets sale
|
-
|
-
|
-
|
-
|
(137.7)
|
-
|
|
Non-recurring PPA impact on EBITDA
|
-
|
-
|
-
|
60.6
|
-
|
-
|
|
Impairment loss on assets and other items
|
-
|
43.0
|
-
|
-
|
75.9
|
-
|
|
Acquisition related expenses
|
-
|
68.5
|
-
|
-
|
174.7
|
-
|
|
Adjusted EBITDA
|
118.9
|
247.4
|
(51.9)
|
477.1
|
997.2
|
(52.2)
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin
|
4.1%
|
9.7%
|
-560 bps
|
5.2%
|
11.3%
|
-610 bps
|
Excluding
PPA effects on SG&A expenses, Selling, Marketing & Logistics expenses reached 40.4% of net revenue (+230 bps), largely
due to higher strategic investments in brand, digital and commercial areas to accelerate future
growth, lower revenue and unfavorable foreign currency impacts, partially offset by lower
bad debt and other savings.
Excluding
PPA effects, Administrative, R&D, IT and Project expenses reached 14.6% of net revenue (+290 bps) in the quarter, mainly due
to lower revenue and foreign currency impacts.
R$ million
|
Q4-20
|
PPA
impacts
|
Q4-20
ex-PPA
|
Q4-19
|
Ch.
%
ex-PPA
|
FY-20
|
PPA
impacts
|
FY-20
ex-PPA
|
FY-19
|
Ch.
%
ex-PPA
|
Selling,
Marketing and Logistics Expenses
|
(1,184.4)
|
(25.1)
|
(1,159.3)
|
(975.8)
|
18.8
|
(3,949.8)
|
(133.2)
|
(3,816.5)
|
(3,414.7)
|
11.8
|
Administrative,
R&D, IT and Projects Expenses
|
(502.1)
|
(82.5)
|
(419.6)
|
(299.4)
|
40.2
|
(1,710.0)
|
(298.4)
|
(1,411.7)
|
(930.7)
|
51.7
|
SG&A
Expenses
|
(1,686.5)
|
(107.6)
|
(1,578.9)
|
(1,275.2)
|
23.8
|
(5,659.8)
|
(431.6)
|
(5,228.2)
|
(4,345.4)
|
20.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling,
Marketing and Logistics Exp./ Net Revenue
|
41.3%
|
-
|
40.4%
|
38.1%
|
230
bps
|
43.4%
|
-
|
42.0%
|
38.6%
|
340
bps
|
Admin.,
R&D, IT, and Projects Exp./ Net Revenue
|
17.5%
|
-
|
14.6%
|
11.7%
|
290
bps
|
18.8%
|
-
|
15.5%
|
10.5%
|
500
bps
|
The
Body Shop: Strong performance driven by our omnichannel approach
In
Q4-20, The Body Shop posted net revenue of R$2,075.9 million, up by 48.4% in BRL (+9.7% at CC), largely driven by direct channels,
with At-Home sales growth of 206% and e-commerce growth of 72%, as well as a significant reduction in discounts. Together, e-commerce
and At-Home represented 40% of total sales in the period and more than offset lost retail sales. UK and Australia were the key
drivers of revenue expansion this quarter, with an exceptional omnichannel performance. Revenue was also supported by the acquisition
of The Body Shop head franchise in Japan, which is now included in retail store revenue.
Black
Friday delivered satisfactory results with 33% sales growth vs. last year, even with the continued strategy of reducing discounts
(by 13 percentage points). With only 78% of own stores open in December (vs. 97% in September), primarily in Europe as the pandemic’s
second wave resulted in new lockdowns, store sales were down 23% vs. Q4-19. In line with the Group’s digitalization strategy,
we launched a new global company website, which enhanced consumer experience and increased the number of new customers. In the
quarter, 50% of total sales were made by new customers. As part of our strategy to expand our omnichannel model in North America,
we grew our At-Home channel to nearly 8,000 consultants.
New
launches in the quarter included Seasonal Body Care range with new Winter Jasmin Fragrance, and the new Lemon Hygiene range. Successful
gifting categories included hero products such as Ginger hair care range and accessibly priced novelty gifts, such as the new
Hand Cream and Bath Blends gifts, in addition to Advent calendars which posted spectacular growth versus the prior year, notably
in At-Home.
Reported
EBITDA in Q4-20 reached R$348.3 million, with EBITDA margin of 16.8% (-730 bps), impacted by a R$144.5 million impairment related
to loss-making legacy stores, predominantly in the US, which were previously included in the original store closure plan and were
further impacted by the pandemic effects. Adjusted EBITDA margin excluding impairment was 23.7% (-290bps), mainly due to the pandemic’s
impact on retail sales, especially in Europe, as well as channel mix effects, including the Japan buyback. FY20 reported
EBITDA margin was 17.5% and adjusted EBITDA margin was 20.2% (-80 bps).
A
reconciliation between EBITDA and adjusted EBITDA is presented below:
|
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
|
|
EBITDA
|
348.3
|
337.0
|
3.4
|
935.3
|
778.2
|
20.2
|
|
Transformation/Integration costs
|
-
|
18.7
|
-
|
-
|
51.5
|
-
|
|
Impairment loss on assets and other items
|
144.5
|
15.9
|
808.8
|
144.5
|
15.9
|
808.8
|
|
Adjusted EBITDA
|
492.8
|
371.6
|
32.6
|
1,079.8
|
845.6
|
27.7
|
|
Adjusted EBITDA Margin
|
23.7%
|
26.6%
|
-290 bps
|
20.2%
|
21.0%
|
-80 bps
|
The
quarter ended with 1,049 own stores and 1,590 franchise stores, with 93 net store closures (own and franchise) since Q4-19. The
increase in own stores is mainly explained by the Japan operation buyback. In the year, we rolled out the new concept store to
13 existing stores and opened 3 new markets with head franchise in Eastern Europe. The chart below shows the store count evolution:
|
|
Store
|
The Body Shop store count
|
|
|
Q4-20
|
Q3-20
|
Q4-19
|
Change vs. Q3-20
|
Change vs. Q4-19
|
|
|
Own
|
1,049
|
959
|
985
|
90
|
64
|
|
|
Franchise
|
1,590
|
1,702
|
1,747
|
(112)
|
(157)
|
|
|
Total
|
2,639
|
2,661
|
2,732
|
(22)
|
(93)
|
Aesop:
Outstanding growth driven by consumer shift to online and Asia recovery
Aesop
posted outstanding net revenue growth of 62.1% in Q4-20 in BRL and +19.3% in constant currency, driven by a remarkable performance
in Asia, notably Japan, now the company’s largest single market, as well as Taiwan and Korea, while sales in Europe, Australia
and New Zealand suffered due to the second wave of Covid-19 lockdowns and a drop in travel. Retail like-for-like sales were down
4%, offset by 190% growth in online sales, representing almost 30% of total revenue, driven by the shift of consumer behavior
and digital innovation features, such as live assistance, new payment platforms, same day delivery, click & collect and the
WeChat e-boutique in Asia. The “adore beauty” live chats in December significantly contributed to increase Aesop’s
page sessions and sell-out sales. In addition, successful Singles’ Day, Black Friday and Festive dates campaigns resulted
in FY20 net revenue growth of 50.0% in BRL (+13.2% at CC).
Aesop
intensified innovation in its home category with a launch of its first ever candle collection, in time for the Christmas season.
In lieu of gift-wrapping, Aesop contributed for every gifting transaction to the Australian Literacy and Numeracy Fund, as part
of its social responsibility practices.
Q4-20
EBITDA stood at R$271.6 million, up 66.1%, with EBITDA margin of 37.1% (+90 bps), driven by top line sales growth and cost discipline.
FY20 EBITDA margin was 31.1% (+410 bps), driven by strong sales growth, strict cost discipline and utilization of government
support programs related to the Covid-19 pandemic.
Signature
stores totalled 247 in the quarter, same as Q4-19, as the store roll out plan was put on hold due to Covid-19. A store count table
is provided below:
Doors
|
Aesop door count
|
Q4-20
|
Q3-20
|
Q4-19
|
Change vs. Q3-20
|
Change vs. Q4-19
|
Signature stores
|
247
|
245
|
247
|
2
|
-
|
Department
|
91
|
90
|
99
|
1
|
(8)
|
Total
|
338
|
335
|
346
|
3
|
(8)
|
|
5.
|
Social and environmental performance
|
(all
actions refer to Natura &Co Group, unless stated otherwise)
|
·
|
This
quarter, we joined/partnered with:
|
|
o
|
One Planet Business for Biodiversity (OP2B):
A unique international cross-sector, action-oriented business coalition on biodiversity with a specific focus on agriculture,
launched in 2019. The coalition is determined to drive transformational systemic change and catalyze action to protect and restore
cultivated and natural biodiversity within value chains and develop and promote policy recommendations for the 2021 CBD COP15
framework.
|
|
·
|
Nominations
and certifications:
|
|
o
|
Corporate Knights: Recognized as one of the
100 most sustainable companies in the Corporate Knights ranking.
|
|
o
|
Dow Jones Sustainability Index (DJSI): Listed
on the emerging markets index for the 7th consecutive year.
|
|
o
|
Corporate Sustainability Index (ISE): Listed
on the B3 (São Paulo stock exchange) index for the 16th consecutive year.
|
|
o
|
B-Corp certification: On December 4, the Natura
brand was certified for the third consecutive time, achieving its best score since 2014 (153 points out of 200 in total). Three
of our four brands are certified (Aesop, Natura and The Body Shop) and this quarter, Natura &Co as a Group received B-Corp
certification, becoming the largest certified company in the world.
|
|
o
|
Most remembered brand on diversity issues:
The Natura brand was the first brand in a ranking of ten companies according to the Oldiversity study, which assesses long-term
impacts of the diversity agenda. The Avon brand was also part of the ranking.
|
|
o
|
Great Place to Work: The Natura brand was recognized
as one of the 25 best companies in the world to work, according to the World’s Best Workplaces 2020 ranking, organized by
Great Place to Work in partnership with Fortune.
|
|
o
|
Ethical trade: The Natura brand obtained UEBT
certification (Union for Ethical BioTrade) attesting to the sustainability of the natural ingredients supply chain for the Ekos
product line.
|
|
o
|
Carbon Disclosure Project (CDP): The Natura
brand was recognized by CDP as a Supplier Engagement Leader in 2020, raising the level of climate ambition throughout our value
chain.
|
|
·
|
Campaign
and program launch:
|
|
o
|
The Body Shop’s TikTok Challenge: “Fight
female homelessness” campaign that aims to help raise awareness and funds to support women and children experiencing homelessness
as consequence of family violence. For every challenge using the hashtag #ShesJustLikeYouAndMe, The Body Shop donated US$5 to
Launch Housing.
|
|
o
|
The Body Shop’s World Kindness Day: Launched
on November 13th, 2020, the campaign offered the chance for the associates to take the day off work with a clear purpose:
be kind to themselves, look after their wellbeing and recharge in whatever way worked best for them.
|
|
o
|
Aesop’s Circular Packaging Trial: Launched
in Oct 2020 in our Adelaide stores in Australia. Offered for our Facial Cleanser formulations in 200ml glass bottles, the purpose
of the trial was to assess customer engagement in a packaging re-use solution. This trial is an instrumental first step as we
look to scale our circular packaging solutions across other products and markets.
|
Natura
2020 Ambition KPIs:
In
2014, the Natura brand launched its 2050 Sustainability Vision, a long-term social and environmental commitment. It guides the
entire business to generate positive impact and contribution for the protection and regeneration of our ecosystem. The first milestone
of this plan is the 2020 Ambition, a set of targets that the Natura brand delivered in 2020.
The
2020 Natura ambition KPIs presented in the table below, are already in line with the three pillars of Natura &Co’s Commitment
to Life Vision for 2030. Starting in Q1-21, we will report Natura &Co’s consolidated performance of the 2030 plan.
Subsequent
Event:
On
February 4, 2021, the Company announced a share repurchase program, concluded on February 8, 2021, for a total of 631,358 common
shares, acquired at market prices in the Brazilian stock exchange. The shares may be used to meet the Company's obligations arising
from its restricted share and stock options programs, and may also be held in treasury, disposed of or cancelled under the terms
of the law.
|
7.
|
Stock Performance (NTCO3/NTCO)
|
NTCO3
shares traded at R$52.5 at the end of Q4-20 on the B3 stock exchange, an appreciation of 2.7% in the quarter. Average Daily Trading
Volume (ADTV) for the quarter was R$377.4 million, an increase of 140.0% vs Q4-19. NTCO traded at US$20.17 at the end of Q4-20
on NYSE, +10.8% in the quarter.
In
the year, NTCO3 appreciated 35.8% vs. 2019, with ADTV of R$343.3 million, an increase of 165.0% vs. 2019. NTCO traded at US$20.17
at the end of the year, +3.6% vs. 2019.
On
December 31, 2020, the Company’s market capitalization was R$72.2 billion, vs. R$33.5 billion in 2019, an increase of 115.6%,
and the Company’s capital was comprised of 1,375,018,140 common shares, vs. 865,659,942 on December 31, 2019.
Below
is the performance of NTCO3 and NTCO in the quarter:
Below
is a table with details of all public debt instruments outstanding per issuer as of December 31, 2020:
Issuer
|
Type
|
Issuance
|
Maturity
|
Principal
(million)
|
Nominal Cost
(per year)
|
Natura Cosméticos S.A.
|
Bonds - 1st issue
|
02/01/2018
|
02/01/2023
|
US$ 750.0 (1)
|
5.375%
|
Natura Cosméticos S.A.
|
Debenture - 7th issue
|
09/25/2017
|
09/25/2021
|
BRL 1,827.3
|
DI + 1.75% per year
|
Natura Cosméticos S.A.
|
Debenture - 9th issue
|
09/21/2018
|
09/21/2021
|
BRL 308.3
|
110.5% DI tax
|
09/21/2022
|
BRL 302.7
|
112% DI tax
|
Natura Cosméticos S.A.
|
Debenture - 10th issue
1st series
|
08/28/2019
|
08/26/2024
|
BRL 400.0
|
DI + 1.00 per year
|
08/29/2019
|
08/26/2024
|
BRL 95.7
|
DI + 1.15 per year
|
BRL 686.2
|
DI + 1.15 per year
|
BRL 394.5
|
DI + 1.15 per year
|
Natura Cosméticos S.A.
|
Promissory Notes - 1st issue
|
05/04/2020
|
05/04/2021
|
BRL 250.0
|
DI + 3.25% per year
|
Avon Products, Inc.
|
Unsecured Bonds
|
03/12/2013
|
03/15/2023
|
US$ 461.9
|
7,000%(2)
|
Avon Products, Inc.
|
Unsecured Bonds
|
03/12/2013
|
03/15/2043
|
US$ 216.1
|
8,950%(2)
|
Natura &Co Holding
|
Promissory Notes - 2nd issue
|
05/04/2020
|
05/04/2021
|
BRL 500.0
|
DI + 3.25% per year
|
|
|
|
|
|
|
(1) Principal and interests fully hedged (swapped to BRL). For more information, see the explanatory notes to the Company’s financial statements.
|
(2) Coupon based on current credit ratings, governed by interest rate adjustment clause
|
Ratings
Below
is a table with our current credit ratings:
Natura Cosméticos S.A.
|
Agency
|
Global Scale
|
National Scale
|
Outlook
|
Standard & Poor's
|
BB
|
brAAA+
|
Stable
|
Fitch Ratings
|
BB
|
AA+ (bra)
|
Stable
|
|
|
|
|
Avon International
|
Agency
|
Global Scale
|
National Scale
|
Outlook
|
Standard & Poor's
|
BB-
|
-
|
Stable
|
Fitch Ratings
|
BB
|
-
|
Stable
|
Moody'sa
|
Ba3
|
-
|
Stable
|
|
|
|
|
a Ugraded on March 3, 2021.
|
|
|
|
As
disclosed on May 7, 2020 Natura &Co raised its estimated synergy gains from the business combination with Avon Products, Inc
by another US$100 million, bringing total expected synergies to between US$300 million and US$400 million on a recurring annual
basis, including new revenue synergies at Natura &Co Latam and cost synergies at Avon International. These amounts are calculated
at an exchange rate of US$1/R$5. The earlier calculation was made at US$1/R$3.87 and would be equivalent to between US$390 million
and US$520 million, up from between US$200 million to US$300 million. These synergies are expected to be captured in full by 2024.
The estimated one-time costs to achieve synergies over this period will be US$190 million, up from US$125 million.
Consolidated
Balance Sheet
ASSETS
(R$ million)
|
Dec-20
|
Dec-19
|
|
LIABILITIES
AND SHAREHOLDER'S EQUITY (R$ million)
|
Dec-20
|
Dec-19
|
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
CURRENT
LIABILITIES
|
|
|
Cash and cash equivalents
|
5,821.7
|
4,513.6
|
|
Loans, financing
and debentures
|
3,805.6
|
3,354.4
|
Securities
|
2,520.6
|
1,025.8
|
|
Leasing
|
1,059.7
|
542.1
|
Trade receivables
|
3,597.5
|
1,685.8
|
|
Trade payables
and forfait operations
|
6,774.2
|
1,829.8
|
Inventories
|
4,544.3
|
1,430.6
|
|
Payroll,
profit sharing and social changes
|
1,340.7
|
560.4
|
Recoverable taxes
|
1,071.3
|
395.6
|
|
Tax liabilities
|
785.4
|
320.9
|
Income tax and social contribution
|
242.1
|
113.5
|
|
Income tax
and social contribution
|
441.3
|
388.2
|
Derivatives
|
139.9
|
-
|
|
Dividends
and interest on shareholders' equity payable
|
-
|
95.9
|
Other current assets
|
616.1
|
265.2
|
|
Derivative
financial instruments
|
61.2
|
11.8
|
Other non-current assets held for sale
|
181.3
|
-
|
|
Provision
for tax, civil and labor risks
|
58.8
|
18.7
|
Total current assets
|
18,734.8
|
9,430.1
|
|
Other current
liabilities
|
1,832.8
|
396.4
|
|
|
|
|
Total current liabilities
|
16,159.6
|
7,518.4
|
NON CURRENT ASSETS
|
|
|
|
|
|
|
Recoverable taxes
|
932.2
|
409.2
|
|
NON CURRENT LIABILITIES
|
|
|
Income tax and social contribution
|
478.5
|
334.7
|
|
Loans, financing
and debentures
|
10,017.3
|
7,432.0
|
Deferred income tax and social contribution
|
1,339.7
|
374.4
|
|
Leasing
|
2,798.8
|
1,975.5
|
Judicial deposits
|
566.2
|
337.3
|
|
Payroll, profit sharing and social changes
|
43.8
|
-
|
Financial derivatives instruments
|
1,768.1
|
737.4
|
|
Tax liabilities
|
109.5
|
122.6
|
Securities
|
16.1
|
7.4
|
|
Deferred
income tax and social contribution
|
1,288.0
|
450.6
|
Other non-current assets
|
1,527.7
|
83.8
|
|
Provision
for tax, civil and labor risks
|
2,000.4
|
201.4
|
Total long term assets
|
6,628.5
|
2,284.2
|
|
Other non-current liabilities
|
1,113.1
|
121.7
|
|
|
|
|
Total non-current liabilities
|
17,370.9
|
10,303.7
|
Property, plant and equipment
|
5,235.1
|
1,773.9
|
|
|
|
|
Intangible assets
|
26,917.1
|
5,076.5
|
|
SHAREHOLDERS' EQUITY
|
|
|
Right of Use
|
3,402.0
|
2,619.9
|
|
Capital
stock
|
12,378.0
|
1,485.4
|
Total non-current assets
|
42,182.8
|
11,754.5
|
|
Treasury
shares
|
(11.7)
|
0.0
|
|
|
|
|
Capital
reserves
|
11,052.1
|
1,210.9
|
|
|
|
|
Retained
earnings
|
120.2
|
(149.0)
|
|
|
|
|
Accumulated
losses
|
(759.9)
|
-
|
|
|
|
|
Equity valuation
adjustment
|
4,585.6
|
815.0
|
|
|
|
|
Equity
attributable to owners of the Company
|
27,364.3
|
3,362.3
|
|
|
|
|
Non-controlling interest on subsidiaries'
equity
|
22.8
|
-
|
|
|
|
|
|
|
|
TOTAL
ASSETS
|
60,917.6
|
21,184.5
|
|
TOTAL
LIABILITIES AND SHAREHOLDERS' EQUITY
|
60,917.6
|
21,184.5
|
Consolidated
Income Statement- Including Purchase Price Allocation (PPA) Amortization
R$ million
|
Q4-20
|
Q4-19
|
Ch. %
|
FY-20
|
FY-19
|
Ch. %
|
NET REVENUE
|
11,997.3
|
4,652.0
|
157.9
|
36,922.0
|
14,444.7
|
155.6
|
Cost of Products Sold
|
(4,280.0)
|
(1,292.6)
|
231.1
|
(13,229.7)
|
(4,033.5)
|
228.0
|
GROSS PROFIT
|
7,717.2
|
3,359.4
|
129.7
|
23,692.3
|
10,411.2
|
127.6
|
OPERATING (EXPENSES) INCOME
|
|
|
|
|
|
|
Selling, Marketing and Logistics Expenses
|
(5,091.4)
|
(1,941.1)
|
162.3
|
(15,702.8)
|
(6,395.6)
|
145.5
|
Administrative, R&D, IT and Project Expenses
|
(1,785.2)
|
(695.6)
|
156.6
|
(5,956.0)
|
(2,405.6)
|
147.6
|
Impairment losses on trade receivables
|
(155.4)
|
(56.9)
|
173.2
|
(727.7)
|
(209.5)
|
247.3
|
Other Operating Income (Expenses), Net
|
(109.0)
|
(49.9)
|
118.5
|
(516.2)
|
(49.3)
|
946.8
|
INCOME (LOSS) FROM OPERATIONS BEFORE FINANCIAL RESULT
|
576.3
|
616.0
|
(6.5)
|
789.6
|
1,351.2
|
(41.6)
|
Financial Income
|
1,183.9
|
682.1
|
73.6
|
4,738.4
|
1,955.8
|
142.3
|
Financial Expenses
|
(1,432.8)
|
(957.0)
|
49.7
|
(5,773.8)
|
(2,795.9)
|
106.5
|
INCOME (LOSS) BEFORE INCOME TAX AND SOCIAL CONTRIBUTION
|
327.3
|
341.1
|
(4.0)
|
(245.8)
|
511.2
|
(148.1)
|
Taxes on Holding Company Constitution
|
-
|
(206.6)
|
(100.0)
|
-
|
(206.6)
|
(100.0)
|
Income Tax and Social Contribution
|
(82.0)
|
(112.2)
|
(26.9)
|
(274.7)
|
(149.1)
|
84.3
|
INCOME (LOSS) FROM CONTINUED OPERATIONS
|
245.3
|
22.3
|
999.9
|
(520.6)
|
155.5
|
(434.8)
|
Income (Loss) from discontinued operations
|
(69.7)
|
-
|
-
|
(143.1)
|
-
|
-
|
NET INCOME (LOSS) FOR THE PERIOD
|
175.7
|
22.3
|
687.5
|
(663.7)
|
155.5
|
(526.9)
|
Attributable to controlling shareholders
|
177.4
|
22.3
|
695.3
|
(650.2)
|
155.5
|
(518.2)
|
Attributable to non-controlling shareholders
|
(1.7)
|
-
|
-
|
(13.5)
|
-
|
-
|
Purchase
Price Allocation (PPA) Amortization
R$ million
|
Q4-20
|
FY-20
|
NET REVENUE
|
-
|
-
|
Cost of Products Sold
|
(23.2)
|
(147.4)
|
GROSS PROFIT
|
(23.2)
|
(147.4)
|
Selling, Marketing and Logistics Expenses
|
(42.0)
|
(259.3)
|
Administrative, R&D, IT and Project Expenses
|
(63.8)
|
(261.2)
|
Impairment losses on trade receivables
|
-
|
-
|
Other Operating Income (Expenses), Net
|
(2.0)
|
(10.8)
|
Transformation/Integration Costs
|
0
|
0
|
Financial Income/(Expenses), net
|
209.4
|
363.2
|
Income Tax and Social Contribution
|
1.5
|
80.1
|
Discontinued operations
|
(37.8)
|
(37.8)
|
INCOME (LOSS) FROM CONTINUED OPERATIONS
|
42.1
|
(273.1)
|
Consolidated
Statements of Cash Flow
R$ million
|
Dec-20
|
Dec-19
|
|
|
|
CASH FLOW FROM OPERATING ACTIVITIES
|
4,472.0
|
2,590.4
|
Increase (Decrease) in:
|
|
|
Trade receivables
|
(1,308.0)
|
(212.8)
|
Inventories
|
(1,444.7)
|
(194.7)
|
Recoverable taxes
|
(770.1)
|
(6.4)
|
Other assets
|
152.8
|
(56.4)
|
Domestic and foreign trade payables
|
1,004.2
|
117.1
|
Payroll, profit sharing and social charges, net
|
749.6
|
(15.9)
|
Tax liabilities
|
382.7
|
91.5
|
Other liabilites
|
(31.1)
|
21.2
|
|
|
|
OTHER CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
Recovery (payment) of income tax and social contribution
|
(331.5)
|
(321.3)
|
Accruals (payments) of judicial deposits
|
66.2
|
9.7
|
Payments related to tax, civil and labor lawsuits
|
(134.6)
|
(27.2)
|
Payments due to settlement of derivative operations
|
(38.8)
|
(66.4)
|
Interest paid on lease
|
(225.4)
|
(134.6)
|
Payment of interest on borrowings, financing and debentures
|
(1,257.7)
|
(493.9)
|
NET CASH GENERATED BY (USED IN) OPERATING ACTIVITIES
|
1,285.6
|
1,300.4
|
|
|
|
CASH FLOW FROM INVESTING ACTIVITIES
|
|
|
Cash from merger of subsidiary
|
2,661.9
|
-
|
Additions of property, plant and equipment and intangible assets
|
(674.2)
|
(586.4)
|
Proceeds from sale of property, plant and equipment and intangible assets
|
104.2
|
22.7
|
Investment in securities
|
(10,371.5)
|
(7,161.5)
|
Redemption of securities
|
9,008.9
|
7,345.4
|
Redemption of interest on investments and securities
|
52.7
|
65.5
|
Investments in subsidiaries
|
(102.9)
|
-
|
|
|
|
NET CASH GENERATED BY (USED IN) BY INVESTING ACTIVITIES
|
679.1
|
(314.3)
|
|
|
|
CASH FLOW FROM FINANCING ACTIVITIES
|
|
|
Amortization of lease - principal
|
(843.3)
|
(497.9)
|
Amortization of loans, financing and debentures – principal
|
(8,483.9)
|
(2,643.6)
|
New loans, financing and debentures
|
1,354.8
|
5,346.1
|
Acquisition of treasury shares, net of option strike price received
|
51.1
|
(2.6)
|
Payment of dividends and interest on capital for the previous year
|
(133.9)
|
(152.9)
|
Receipts (payments) to settle derivative operations
|
211.7
|
4.0
|
Obligation of the acquiree incurred by the acquirer
|
(370.8)
|
-
|
Receipts from stock options exercise
|
-
|
52.7
|
Capital increase
|
7,436.7
|
206.6
|
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
|
(777.6)
|
2,312.4
|
|
|
|
Effect of exchange variation on cash and cash equivalents
|
121.0
|
0.1
|
|
|
|
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
1,308.1
|
3,298.5
|
Opening balance of cash and cash equivalents
|
4,513.6
|
1,215.0
|
Closing balance of cash and cash equivalents
|
5,821.7
|
4,513.6
|
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
1,308.1
|
3,298.5
|
|
11.
|
Conference call and webcast
|
Webcast link: ri.naturaeco.com
Abihpec:
Brazilian Association of the Personal Hygiene, Perfumery and Cosmetics Industry
ADR:
An American Depositary Receipt is a negotiable certificate issued by a U.S. depository bank representing a specified number
of shares of a non-U.S. company stock.
ADS:
The individual issuance of shares in a U.S. stock exchange by a non-U.S. company is referred to as American Depositary Shares
(ADS)
Adjusted
EBITDA: Excludes effects that are not considered usual, recurring or not-comparable between the periods under analysis
APAC:
Asia and Pacific
Avon
representatives: Self-employed resellers who do not have a formal labor relationship with Avon
B3:
Brazilian Stock Exchange
Benefit
Sharing: In accordance with Natura’s Policy for the Sustainable Use of Biodiversity and Associated Traditional Knowledge,
benefits are shared whenever we perceive various forms of value in the access gained. Therefore, one of the practices that defines
the way in which these resources are divided is to associate payments with the number of raw materials produced from each plant
as well as the commercial success of the products in which these raw materials are used
BPS:
Basis Points; a basis points is equivalent to one percentage point * 100
BRL:
Brazilian Reais
CDI:
The overnight rate for interbank deposits
CFT:
Cosmetics, Fragrances and Toiletries Market (CFT = Fragrances, Body Care and Oil Moisture, Make-up (without Nails), Face Care,
Hair Care (without Colorants), Soaps, Deodorants, Men’s Grooming (without Razors) and Sun Protection
COGS:
Costs of Goods Sold
Constant
currency (“CC) or constant exchange rates: when exchange rates used to convert financial figures into a reporting currency
are the same for the years under comparison, excluding foreign currency fluctuation effects
CO2e: Carbon
dioxide equivalent; for any quantity and type of greenhouse gas, CO2e signifies the amount of CO2 which would have the
equivalent global warming impact.
EBITDA:
Earnings Before Interests, Tax, Depreciation and Amortization
EMEA:
Europe, Middle East and Africa
EP&L:
Environmental Profit & Loss
Foreign
currency translation: conversion of figures from a foreign currency into the currency of the reporting entity
G&A:
General and administrative expenses
GHG:
Greenhouse gases
ICON:
Consumer Stock Index of the B3 stock exchange, designed to track changes in the prices of the more actively traded and better
representative cyclical and non-cyclical consumer stocks
Innovation
Index: Share in the last 12 months of the sale of products launched in the last 24 months
IBOV:
Ibovespa Index is the main performance indicator of the stocks traded in B3 and lists major companies in the Brazilian capital
market
IFRS
– International Financial Reporting Standards
Kantar:
Data, insights and consulting company with global presence
Hispanic
Latam: Often used to refer to the countries in Latin America, excluding Brazil
LFL:
Like-for-Like, applicable to measure comparable growth
Natura
Consultant: Self-employed resellers who do not have a formal labor relationship with Natura
Natura
Crer Para Ver Program (CPV): Special line of non-cosmetic products whose profits are transferred to the Natura Institute,
in Brazil, and invested by Natura in social initiatives in the other countries where we operate. Our consultants promote these
sales to benefit society and do not obtain any gains.
Natura
Institute: Is a nonprofit organization created in 2010 to strengthen and expand our Private Social Investment initiatives.
The institute has enabled us to leverage our efforts and investments in actions that contribute to the quality of public education
NYSE:
New York Stock Exchange
P&L:
Profit and loss
PP:
Percentage point
PPA:
Purchase Price Allocation - effects of the fair market value assessment as a result of a business combination
Profit
Sharing: The share of profit allocated to employees under the profit-sharing program
SEC:
The U.S. Securities and Exchange Commission (SEC) is an independent federal government regulatory agency responsible for protecting
investors, maintaining fair and orderly functioning of the securities markets, and facilitating capital formation
SG&A:
Selling, general and administrative expenses
SM&L:
Selling, marketing and logistics expenses
SSS:
Same-Store-Sales
Supplier
Communities: The communities of people involved in small–scale farming and extraction activities in a variety of locations
in Brazil, especially in the Amazon Region, who extract the inputs used in our products from the social and biodiversity. We form
production chains with these communities that are based on fair prices, the sharing of benefits gained from access to the genetic
heritage and associated traditional knowledge and support for local sustainable development projects. This business model has
proven effective in generating social, economic and environmental value for Natura and for the communities.
Synergies:
Synergy is the concept that the value and performance of two companies combined will be greater than the sum of the separate
individual parts.
TBS:
The Body Shop.
UNI:
Underlying Net Income.
EBITDA
is not a measure under BR GAAP and does not represent cash flow for the periods presented. EBITDA should not be considered an
alternative to net income as an indicator of operating performance or an alternative to cash flow as an indicator of liquidity.
EBITDA does not have a standardized meaning and the definition of EBITDA used by Natura may not be comparable with that used by
other companies. Although EBITDA does not provide under BR GAAP a measure of cash flow, Management has adopted its use to measure
the Company’s operating performance. Natura also believes that certain investors and financial analysts use EBITDA as an
indicator of performance of its operations and/or its cash flow.
This
report contains forward-looking statements. These forward-looking statements are not historical fact, but rather reflect the wishes
and expectations of Natura’s management. Words such as "anticipate," "wish," "expect," "foresee,"
"intend," "plan," "predict," "project," "desire" and similar terms identify
statements that necessarily involve known and unknown risks. Known risks include uncertainties that are not limited to the impact
of price and product competitiveness, the acceptance of products by the market, the transitions of the Company’s products
and those of its competitors, regulatory approval, currency fluctuations, supply and production difficulties and changes in product
sales, among other risks. This report also contains certain pro forma data, which are prepared by the Company exclusively for
informational and reference purposes and as such are unaudited. This report is updated up to the present date and Natura does
not undertake to update it in the event of new information and/or future events.
Investor Relations Team
Tel.: +55 (11) 4389-7881
ri@natura.net